Implementation of Affordable Care Act expands access to early-stage breast cancer diagnosis

NewsGuard 100/100 Score

Minority women and women in general aged 50-64 in Pennsylvania showed an increased proportion of early-stage breast cancer diagnosis since the implementation of the Affordable Care Act (ACA).

Under the ACA, more women are able to get early breast health screening. The study is published in the peer-reviewed Journal of Women's Health.

For women aged 50-64, both non-Hispanic white women (86.54% pre-ACA, 88.09% post-ACA) and minority women (83.12% pre-ACA, 85.83% post-ACA) had a significantly increased proportion of early stage breast cancer diagnosis post-ACA.

"The ACA expanded access to affordable insurance coverage, making it possible for more women to undergo regular breast cancer screening.

This study demonstrates the benefits that this can have for early breast cancer diagnosis and the ability to begin to mitigate some of the racial disparities in early detection," says Journal of Women's Health Editor-in-Chief Susan G. Kornstein, MD, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA.

Future research should identify those disadvantaged populations for whom disparities in healthcare remain pronounced despite the ACA. It should also explore the variables that contribute to healthcare disparities, but are not addressed by the ACAs insurance expansion, such as social determinants of health that impact healthcare access and outcomes."

Neal Spade, MD, Study Co-Author, University of Pittsburgh

Source:
Journal reference:

Spada, N. G., et al. (2020) Changes in Disparities in Stage of Breast Cancer Diagnosis in Pennsylvania After the Affordable Care Act. Journal of Women's Health. doi.org/10.1089/jwh.2020.8478.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Aspirin shows no benefit in preventing breast cancer recurrence, study finds